Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The relationship between antihypertensive medications and mood disorders: analysis of linked healthcare data for 1.8 million patients
Richard Shaw, Daniel Mackay, Jill P. Pell, et al.
Psychological Medicine (2020) Vol. 51, Iss. 7, pp. 1183-1191
Open Access | Times Cited: 21

Showing 21 citing articles:

Antihypertensive Drugs and Risk of Depression
Lars Vedel Kessing, Helene C. W. Rytgaard, Claus Thorn Ekstrøm, et al.
Hypertension (2020) Vol. 76, Iss. 4, pp. 1263-1279
Closed Access | Times Cited: 67
Microvascular Contribution to Late-Onset Depression: Mechanisms, Current Evidence, Association With Other Brain Diseases, and Therapeutic Perspectives
Jean‐Philippe Empana, Pierre Boutouyrie, Cédric Lemogne, et al.
Biological Psychiatry (2021) Vol. 90, Iss. 4, pp. 214-225
Open Access | Times Cited: 45
Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders
Lucy Colbourne, Paul J. Harrison
Molecular Psychiatry (2022) Vol. 27, Iss. 9, pp. 3904-3912
Open Access | Times Cited: 36
Biases arising from linked administrative data for epidemiological research: a conceptual framework from registration to analyses
Richard Shaw, Katie Harron, Júlia Moreira Pescarini, et al.
European Journal of Epidemiology (2022) Vol. 37, Iss. 12, pp. 1215-1224
Open Access | Times Cited: 33
Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations
Bohan Fan, Jie Zhao
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Dietary fibre and the gut–brain axis: microbiota-dependent and independent mechanisms of action
Danique La Torre, Kristin Verbeke, Boushra Dalile
Gut Microbiome (2021) Vol. 2
Open Access | Times Cited: 28
CACNA1C (CaV1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: Advances from functional genomics and pharmacoepidemiology
Paul J. Harrison, Syed Masood Husain, Hami Lee, et al.
Neuropharmacology (2022) Vol. 220, pp. 109262-109262
Open Access | Times Cited: 21
Letter to the Editor: Discussion on the suicide risk of CCB drugs: based on real-world drug safety surveillance
Dongqiang Luo, Jiayu Wu, Bingshuo Liu
Psychological Medicine (2025), pp. 1-3
Closed Access
Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore
Juan M. Saavedra
Physiology (2021) Vol. 36, Iss. 3, pp. 160-173
Closed Access | Times Cited: 26
Association between antihypertensive drug use and the risk of depression: a systematic review and network meta-analysis
Jay Tewari, Khalid Ahmad Qidwai, Ajoy Tewari, et al.
Journal of Human Hypertension (2025)
Closed Access
Rates of delirium associated with calcium channel blockers compared to diuretics, renin-angiotensin system agents and beta-blockers: An electronic health records network study
Paul J. Harrison, Sierra Luciano, Lucy Colbourne
Journal of Psychopharmacology (2020) Vol. 34, Iss. 8, pp. 848-855
Open Access | Times Cited: 26
Onset and recurrence of psychiatric disorders associated with anti-hypertensive drug classes
Lucy Colbourne, Sierra Luciano, Paul J. Harrison
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Hypertension and psychosis
Yauvani Sudarshan, Bernard M.Y. Cheung
Postgraduate Medical Journal (2022) Vol. 99, Iss. 1171, pp. 411-415
Closed Access | Times Cited: 9
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension
Thomas T. van Sloten, Patrick C. Souverein, Coen D.A. Stehouwer, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 5, pp. 594-603
Open Access | Times Cited: 9
Blood pressure in bipolar disorder: evidence of elevated pulse pressure and associations between mean pressure and mood instability
Niall M. McGowan, Molly Nichols, Amy C. Bilderbeck, et al.
International Journal of Bipolar Disorders (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Associations of Cardiovascular Agents and Metformin with Depression Symptoms: A Cross-Sectional Analysis from the HUNT Study, Norway
Ivana Bojanić, Ottar Bjerkeset, Lana J. Williams, et al.
Drugs - Real World Outcomes (2022) Vol. 9, Iss. 3, pp. 503-516
Open Access | Times Cited: 5
Risk of antidepressant initiation among users of cardiovascular agents and metformin.
Ivana Bojanić, Ottar Bjerkeset, Lana J. Williams, et al.
Pharmacology Research & Perspectives (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 2
Association Between Lipophilic Beta-Blockers and Depression in Diabetic Patients on Chronic Dialysis
Robin Lengton, Robbert W. Schouten, Els Nadort, et al.
Clinical Medicine Insights Endocrinology and Diabetes (2022) Vol. 15
Open Access | Times Cited: 3
The causal relationship between antihypertensive drugs and depression: a Mendelian randomization study of drug targets
Zixian Yang, Jinshuai Li, Peichu Huang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Differences in the Microbial Composition of Hemodialysis Patients Treated With and Without β-Blockers
Yi‐Ting Lin, Ting‐Yun Lin, Szu‐Chun Hung, et al.
Research Square (Research Square) (2020)
Open Access
Distinct effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on major depressive disorder: A nationwide cohort study
Jun Myong Lee, Seulggie Choi, Seogsong Jeong, et al.
Asian Journal of Psychiatry (2022) Vol. 81, pp. 103436-103436
Closed Access
Page 1

Scroll to top